Article Details

Phrontline Biopharma Announces First Patient Dosed in Phase 1 Clinical Trial of TJ101

Retrieved on: 2025-09-15 00:06:32

Tags for this article:

Click the tags to see associated articles and topics

Phrontline Biopharma Announces First Patient Dosed in Phase 1 Clinical Trial of TJ101. View article details on hiswai:

Excerpt

Phrontline Biopharma, a clinical-stage biotechnology company advancing a new generation of Antibody-Drug Conjugates (ADCs), today announced that ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo